1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South America Pulmonary Arterial Hypertension Market – By Drugs

1.3.2        South America Pulmonary Arterial Hypertension Market – By Type

1.3.3        South America Pulmonary Arterial Hypertension Market – By Route of Administration

1.3.4        South America Pulmonary Arterial Hypertension Market – By Distribution Channel

1.3.5        South America Pulmonary Arterial Hypertension Market – By Country

2.           South America Pulmonary Arterial Hypertension Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South America Pulmonary Arterial Hypertension Market – Market Landscape

4.1         Overview

4.2         South America PEST Analysis

4.3         Experts Opinion

5.           South America Pulmonary Arterial Hypertension Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Incidence of Pulmonary Arterial Hypertension

5.2         Market Restraints

5.2.1        Side Effects of Drugs Used for Treatment of Pulmonary Arterial Hypertension

5.3         Market Opportunities

5.3.1        Availability of Generics at Affordable Costs Due to Growing Patent Expiration

5.4         Future Trend

5.4.1        Rising Clinical Trials for Drugs Development to Treat Pulmonary Arterial Hypertension

5.5         Impact analysis

6.           Pulmonary Arterial Hypertension Market – South America Analysis

6.1         South America Pulmonary Arterial Hypertension Market Revenue Forecast and Analysis

7.           South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Drugs

7.1         Overview

7.2         South America Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)

7.3         Endothelin Receptor Antagonists (ERAs)

7.3.1        Overview

7.3.2        Endothelin Receptor Antagonists (ERAs): South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Prostacyclin and Prostacyclin Analogs

7.4.1        Overview

7.4.2        Prostacyclin and Prostacyclin Analogs: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.5         SGC Stimulators

7.5.1        Overview

7.5.2        sGC Stimulators: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Pde-5 Dipsticks

7.6.1        Overview

7.6.2        Pde-5 Dipsticks: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

8.           South America Pulmonary Arterial Hypertension Market Analysis and Forecasts to 2028 – by Type

8.1         Overview

8.2         South America Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)

8.3         Branded

8.3.1        Overview

8.3.2        Branded: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Generics

8.4.1        Overview

8.4.2        Generics: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.           South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Route of Administration

9.1         Overview

9.2         South America Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)

9.3         Oral

9.3.1        Overview

9.3.2        Oral: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Intravenous/ Subcutaneous

9.4.1        Overview

9.4.2        Intravenous/ Subcutaneous: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Inhalational

9.5.1        Overview

9.5.2        Inhalational: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.        South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – by Distribution Channel

10.1      Overview

10.2      South America Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)

10.3      Hospital Pharmacies and Clinics

10.3.1     Overview

10.3.2     Hospital Pharmacies and Clinics: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Online Pharmacies

10.4.1     Overview

10.4.2     Online Pharmacies: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Retail Pharmacies

10.5.1     Overview

10.5.2     Retail Pharmacies: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.        South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 – Country Analysis

11.1      Overview

11.1.2     South & Central America: Pulmonary Arterial Hypertension Market, by Country, 2021 & 2028 (%)

11.1.2.1       Brazil: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.1.1       Overview

11.1.2.1.2       Brazil: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.1.3       Brazil: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.2.1.4       Brazil: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.2.1.5       Brazil: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.2.1.6       Brazil: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.2.2       Argentina: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.2.1       Overview

11.1.2.2.2       Argentina: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.2.3       Argentina: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.2.2.4       Argentina: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.2.2.5       Argentina: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.2.2.6       Argentina: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

11.1.2.3       Rest of South America: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.3.1       Overview

11.1.2.3.2       Rest of South America: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.3.3       Rest of South America: Pulmonary Arterial Hypertension Market, by Drugs, 2019–2028 (US$ Million)

11.1.2.3.4       Rest of South America: Pulmonary Arterial Hypertension Market, by Type, 2019–2028 (US$ Million)

11.1.2.3.5       Rest of South America: Pulmonary Arterial Hypertension Market, by Route of Administration, 2019–2028 (US$ Million)

11.1.2.3.6       Rest of South America: Pulmonary Arterial Hypertension Market, by Distribution Channel, 2019–2028 (US$ Million)

12.        South America Pulmonary Arterial Hypertension Market – Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Johnson & Johnson

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Gilead Sciences Inc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Novartis AG

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GSK Plc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Teva Pharmaceutical Industries Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Lupin Ltd

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Pfizer Inc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             South America: Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil: Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil: Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil: Pulmonary Arterial Hypertension Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 5.             Brazil: Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Argentina: Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina: Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Argentina: Pulmonary Arterial Hypertension Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 9.             Argentina: Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Rest of South America: Pulmonary Arterial Hypertension Market, by Drugs – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of South America: Pulmonary Arterial Hypertension Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of South America: Pulmonary Arterial Hypertension Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of South America: Pulmonary Arterial Hypertension Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Organic Developments in the South America pulmonary arterial hypertension market

Table 15.          Inorganic Developments in the South America pulmonary arterial hypertension market

Table 16.          Glossary of Terms

LIST OF FIGURES

Figure 1.           South America Pulmonary Arterial Hypertension Market Segmentation

Figure 2.           South America Pulmonary Arterial Hypertension Market – By Country

Figure 3.           South America Pulmonary Arterial Hypertension Market Overview

Figure 4.           Prostacyclin and Prostacyclin Analogs Segment Held Largest Share by Drugs of the South America Pulmonary Arterial Hypertension Market

Figure 5.           Brazil to Show Significant Growth During Forecast Period

Figure 6.           South America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           South America Pulmonary Arterial Hypertension Market Impact Analysis of Drivers and Restraint

Figure 9.           South America Pulmonary Arterial Hypertension Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10.        South America Pulmonary Arterial Hypertension Market Revenue Share, by Drugs 2021 & 2028 (%)

Figure 11.        Endothelin Receptor Antagonists (ERAs): South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Prostacyclin and Prostacyclin Analogs: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        sGC Stimulators: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Pde-5 Dipsticks: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        South America Pulmonary Arterial Hypertension Market, by Type 2021 & 2028 (%)

Figure 16.        Branded: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Generics: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        South America Pulmonary Arterial Hypertension Market Revenue Share, by Route of Administration 2021 & 2028 (%)

Figure 19.        Oral: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Intravenous/ Subcutaneous: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Inhalational: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        South America Pulmonary Arterial Hypertension Market Revenue Share, by Distribution Channel 2021 & 2028 (%)

Figure 23.        Hospital Pharmacies and Clinics: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Online Pharmacies: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Retail Pharmacies: South America Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        South & Central America: Pulmonary Arterial Hypertension Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27.        South & Central America: Pulmonary Arterial Hypertension Market, by Country, 2021 & 2028 (%)

Figure 28.        Brazil: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Argentina: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.          Rest of South America: Pulmonary Arterial Hypertension Market – Revenue and Forecast to 2028 (US$ Million)